Plant Comparison
Oregon Grape vs Marjoram
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Oregon Grape and Marjoram: they share 5 indicated uses (arthritis / joint pain, infection (general), inflammation (general), …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Oregon Grape | Marjoram | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 7/10 | 1/10 | Stronger for Oregon Grape |
| Infection (general) | 2/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 7/10 | 2/10 | Stronger for Oregon Grape |
| Skin irritation | 8/10 | 1/10 | Stronger for Oregon Grape |
| Wounds | 1/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The volatile oil, dominated by terpinen-4-ol and cis-sabinene hydrate in true sweet marjoram, gives most of the antimicrobial and antioxidant activity.
Contribute to antioxidant and anti-inflammatory activity.
Pharmacological Actions
Anti-inflammatory and antiproliferative (slows the skin-cell overgrowth of psoriasis)
Anti-inflammatory and antiproliferative (slows the skin-cell overgrowth of psoriasis)
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from anticancer action
Topical for atopic dermatitis (eczema) and skin irritation
Antimicrobial (berberine) - supports skin and mucosal infection
inferred from anti-inflammatory action
Anti-inflammatory and antiproliferative (slows the skin-cell overgrowth of psoriasis); Topical treatment of mild-to-moderate psoriasis (reduces plaque severity) - a double-blind, placebo-controlled RCT showed significant improvement in PASI and quality-of-life scores
Topical for atopic dermatitis (eczema) and skin irritation
inferred from anti-inflammatory action
inferred from digestive action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from sedative action
inferred from antispasmodic action
inferred from antispasmodic action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Avoid internal use in pregnancy and breastfeeding: like goldenseal, the berberine it contains can cross the placenta and into milk and worsen newborn jaundice (kernicterus risk).
Generally very safe as a culinary herb. Essential oil should not be ingested in large amounts and avoided in pregnancy. Theoretically may interact with anticoagulants. Avoid medicinal doses during pregnancy.
Duke (2002) rates marjoram (Origanum majorana) as +++ and notes antiviral, antispasmodic, COX-2 inhibitory, and antiseptic activities at the experimental level (score 1). It demonstrates antiherpetic activity in vitro. The plant contains rosmarinic acid and thymol, which contribute to antioxidant and antimicrobial effects. Dose: 1–2 g dried herb as tea three times daily or equivalent preparations. Duke notes the plant is generally well-tolerated with no significant contraindications at usual herbal doses (Duke, 2002).
External Ids
Botanical Description
Evergreen shrub, 0.5-2 m tall, spreading by underground rhizomes to form thickets. The pinnate leaves resemble holly, with 5-9 glossy, dark green, spiny-toothed leaflets that often turn bronze-red in winter. Small, bright yellow, six-petalled flowers are borne in dense, upright terminal racemes in early spring, followed by clusters of blue-black, grape-like berries with a waxy bloom. The wood and inner bark of the stem and root are bright yellow when cut, owing to their high content of berberine-type alkaloids.
Tender perennial subshrub (Lamiaceae), often grown as an annual in cold climates, 20-60 cm tall, with square, downy, much-branched stems. Leaves are opposite, small, grey-green and ovate. Tiny white to pale pink, two-lipped flowers are borne in distinctive knot-like clustered spikes, the origin of the common name 'knotted marjoram'.[6]
Habitat
Native to the Pacific Northwest of North America, growing in coniferous woodland understorey, forest margins and rocky slopes; widely introduced and naturalised as an ornamental and hedging shrub in temperate regions elsewhere.
Native to Cyprus, Turkey and the eastern Mediterranean, and widely cultivated as a culinary and medicinal herb in gardens worldwide; prefers full sun and well-drained, often calcareous soils.[6]
Harvesting
The root and root bark, the medicinal parts, are dug from established plants - traditionally in autumn - and dried. Because wild populations are slow-growing, cultivated or nursery-sourced material is preferred over wild-harvesting.
The aerial flowering parts are cut just before or at flowering (summer), when essential-oil content is highest, and dried quickly in a warm, shaded, well-ventilated place.[9]
Traditional Uses
Oregon grape root has a traditional Native American and Eclectic-medicine history as a bitter tonic and alterative (blood-purifying) remedy and for skin conditions. Its main modern use, supported by clinical trials, is topical application of a standardised bark extract for mild-to-moderate psoriasis and atopic dermatitis (eczema), where its berberine-type alkaloids give anti-inflammatory and antiproliferative effects on skin cells.[1, 11, 12]
Marjoram has a long Mediterranean culinary-medicinal tradition as a digestive carminative and mild sedative for indigestion, cramping and poor sleep, and as an antiseptic for minor wounds and infections. Modern research confirms antispasmodic, antimicrobial, antioxidant and anti-inflammatory activity from its essential oil and phenolic constituents.[6, 8]
Preparations
Dosage
References
Lookalikes Review
Drug Class Interactions
Not documented
References & Sources
- Gulliver, W.P. and Donsky, H.J (2005) 'A report on three recent clinical trials using Mahonia aquifolium 10% topical cream and a review of the worldwide clinical experience with Mahonia aquifolium for the treatment of plaque psoriasis', American Journal of Therapeutics, 12(5), pp. 398-406. doi:10.1097/01.mjt.0000174350.82270.da Clinical study
https://doi.org/10.1097/01.mjt.0000174350.82270.da - Cernakova, M. and Kostalova, D (2002) 'Antimicrobial activity of berberine--a constituent of Mahonia aquifolium', Folia Microbiologica, 47(4), pp. 375-378. doi:10.1007/BF02818693 Preclinical
https://doi.org/10.1007/BF02818693 - Damjanovic, A., Kolundzija, B., Matic, I.Z., Krivokuca, A. and others (2020) 'Mahonia aquifolium Extracts Promote Doxorubicin Effects against Lung Adenocarcinoma Cells In Vitro', Molecules, 25(22), pp. 5233. doi:10.3390/molecules25225233 Preclinical
https://doi.org/10.3390/molecules25225233 - Cernakova, M., Kostalova, D., Kettmann, V., Plodova, M. and others (2002) 'Potential antimutagenic activity of berberine, a constituent of Mahonia aquifolium', BMC Complementary and Alternative Medicine, 2, pp. 2. doi:10.1186/1472-6882-2-2 Preclinical
https://doi.org/10.1186/1472-6882-2-2 - Slobodnikova, L., Kostalova, D., Labudova, D., Kotulova, D. and Kettmann, V (2004) 'Antimicrobial activity of Mahonia aquifolium crude extract and its major isolated alkaloids', Phytotherapy Research, 18(8), pp. 674-676. doi:10.1002/ptr.1517 Preclinical
https://doi.org/10.1002/ptr.1517 - Godjevac, D., Damjanovic, A., Stanojkovic, T.P., Andjelkovic, B. and Zdunic, G (2018) 'Identification of cytotoxic metabolites from Mahonia aquifolium using 1H NMR-based metabolomics approach', Journal of Pharmaceutical and Biomedical Analysis, 150, pp. 9-14. doi:10.1016/j.jpba.2017.11.075 Preclinical
https://doi.org/10.1016/j.jpba.2017.11.075 - Muller, K. and Ziereis, K (1994) 'The antipsoriatic Mahonia aquifolium and its active constituents; I. Pro- and antioxidant properties and inhibition of 5-lipoxygenase', Planta Medica, 60(5), pp. 421-424. doi:10.1055/s-2006-959523 Preclinical
https://doi.org/10.1055/s-2006-959523 - Rohrer, U., Kunz, E.M.K., Lenkeit, K., Schaffner, W. and Meyer, J (2007) 'Antimicrobial activity of Mahonia aquifolium and two of its alkaloids against oral bacteria', Schweizer Monatsschrift fur Zahnmedizin, 117(11), pp. 1126-1131. Preclinical
https://scholar.google.com/scholar?q=Antimicrobial%20activity%20of%20Mahonia%20aquifolium%20and%20two%20of%20its%20alkaloids%20against%20oral%20bacteria - Vollekova, A., Kostalova, D., Kettmann, V. and Toth, J (2003) 'Antifungal activity of Mahonia aquifolium extract and its major protoberberine alkaloids', Phytotherapy Research, 17(7), pp. 834-837. doi:10.1002/ptr.1256 Preclinical
https://doi.org/10.1002/ptr.1256 - Hajnicka, V., Kostalova, D., Svecova, D., Sochorova, R. and others (2002) 'Effect of Mahonia aquifolium active compounds on interleukin-8 production in the human monocytic cell line THP-1', Planta Medica, 68(3), pp. 266-268. doi:10.1055/s-2002-23126 Preclinical
https://doi.org/10.1055/s-2002-23126 - Gulliver, W.P. and colleagues (2018) 'Review of the Efficacy and Safety of Topical Mahonia aquifolium for the Treatment of Psoriasis and Atopic Dermatitis', Journal of Clinical and Aesthetic Dermatology. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334833/ Meta-analysis / review
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334833/ - Herbal Reality (n.d.) 'Oregon Grape Root (Berberis aquifolium): Benefits, Uses, Safety'. Available at: https://www.herbalreality.com/herb/oregon-grape/ Traditional / reference
https://www.herbalreality.com/herb/oregon-grape/ - Bernstein, S., Donsky, H., Gulliver, W., Hamilton, D., Nobel, S. and Norman, R (2006) 'Treatment of mild to moderate psoriasis with Relieva, a Mahonia aquifolium extract - a double-blind, placebo-controlled study', American Journal of Therapeutics, 13(2), pp. 121--126. doi:10.1097/00045391-200603000-00007 Randomized trial
https://doi.org/10.1097/00045391-200603000-00007
- Rehman, N.U., Ansari, M.N., Ahmad, W. and Ali, A (2024) 'Calcium Channel Inhibitory Effect of Marjoram (Origanum majorana L.): Its Medicinal Use in Diarrhea and Gut Hyperactivity', Frontiers in Bioscience (Landmark Edition), 29(2), pp. 47. doi:10.31083/j.fbl2902047 Preclinical
https://doi.org/10.31083/j.fbl2902047 - Hussein, Z. and Yasir, S.M (2022) 'Origanum majorana attenuates ciprofloxacin-induced nephropathy in rats', Wiadomosci Lekarskie, 75(12), pp. 3046-3049. doi:10.36740/WLek202212126 Preclinical
https://doi.org/10.36740/WLek202212126 - Elfiky, A.M., Ibrahim, R.S., Khattab, A.R., Kadry, M.O. and others (2025) 'Exploring the therapeutic potential of marjoram (Origanum majorana L.) in polycystic ovary syndrome: insights from serum metabolomics, network pharmacology and experimental validation', BMC Complementary Medicine and Therapies, 25(1), pp. 67. doi:10.1186/s12906-025-04774-5 Preclinical
https://doi.org/10.1186/s12906-025-04774-5 - Waller, S.B., Cleff, M.B., de Mattos, C.B., da Silva, C.C. and others (2021) 'Protection of the marjoram (Origanum majorana Linn.) essential oil in cutaneous sporotrichosis caused by Sporothrix brasiliensis', Natural Product Research, 35(17), pp. 2977-2981. doi:10.1080/14786419.2019.1678617 Preclinical
https://doi.org/10.1080/14786419.2019.1678617 - Haj-Husein, I., Tukan, S. and Alkazaleh, F (2016) 'The effect of marjoram (Origanum majorana) tea on the hormonal profile of women with polycystic ovary syndrome: a randomised controlled pilot study', Journal of Human Nutrition and Dietetics, 29(1), pp. 105-111. doi:10.1111/jhn.12290 Randomized trial
https://doi.org/10.1111/jhn.12290 - Bouyahya, A., Chamkhi, I., Benali, T., Guaouguaou, F.E. and others (2021) 'Traditional use, phytochemistry, toxicology, and pharmacology of Origanum majorana L', Journal of Ethnopharmacology, 265, pp. 113318. doi:10.1016/j.jep.2020.113318 Meta-analysis / review
https://doi.org/10.1016/j.jep.2020.113318 - Al-Howiriny, T., Alsheikh, A., Alqasoumi, S., Al-Yahya, M. and others (2009) 'Protective Effect of Origanum majorana L. 'Marjoram' on various models of gastric mucosal injury in rats', The American Journal of Chinese Medicine, 37(3), pp. 531-545. doi:10.1142/S0192415X0900703X Preclinical
https://doi.org/10.1142/S0192415X0900703X - Bina, F. and Rahimi, R (2017) 'Sweet Marjoram: A Review of Ethnopharmacology, Phytochemistry, and Biological Activities', Journal of Evidence-Based Complementary & Alternative Medicine, 22(1), pp. 175-185. doi:10.1177/2156587216650793 Meta-analysis / review
https://doi.org/10.1177/2156587216650793 - Paudel, P.N., Satyal, P., Satyal, R., Setzer, W.N. and others (2022) 'Chemical Composition, Enantiomeric Distribution, Antimicrobial and Antioxidant Activities of Origanum majorana L. Essential Oil from Nepal', Molecules, 27(18), pp. 6136. doi:10.3390/molecules27186136 Preclinical
https://doi.org/10.3390/molecules27186136 - Makrane, H., Aziz, M., Mekhfi, H., Ziyyat, A. and others (2019) 'Origanum majorana L. extract exhibit positive cooperative effects on the main mechanisms involved in acute infectious diarrhea', Journal of Ethnopharmacology, 239, pp. 111503. doi:10.1016/j.jep.2018.09.005 Preclinical
https://doi.org/10.1016/j.jep.2018.09.005 - Baser, K.H.C (2008) 'Biological and pharmacological activities of carvacrol and carvacrol bearing essential oils', 14(29), pp. 3106--3119. doi:10.2174/138161208786404227 Traditional / reference
https://doi.org/10.2174/138161208786404227 - Hoffmann, D (2003) 'Medical Herbalism'. Traditional / reference
https://scholar.google.com/scholar?q=Medical%20Herbalism - Seidler-Lozykowska, K. et al (2016) 'Essential oil content and composition of sweet marjoram (Origanum majorana L.) grown in Poland', 62(1), pp. 37--45. Traditional / reference
https://scholar.google.com/scholar?q=Essential%20oil%20content%20and%20composition%20of%20sweet%20marjoram%20%28Origanum%20majorana%20L.%29%20grown%20in%20Poland - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.